Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs.
Finn JungRaphaela StaltnerAmmar TahirAnja BaumannKatharina BurgerEmina HalilbasicClaus HellerbrandIna BergheimPublished in: European journal of nutrition (2022)
The results of our study suggest that an ingestion of low doses of xanthohumol can suppress the LTA-dependent stimulation of PBMCs through mechanisms involving the interaction of CD14 with TLR2. Study registered at ClinicalTrials.gov (NCT04847193, 22.03.2022).